Thermo Fisher Scientific Debt to Equity Ratio 2010-2025 | TMO
Current and historical debt to equity ratio values for Thermo Fisher Scientific (TMO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Thermo Fisher Scientific debt/equity for the three months ending March 31, 2025 was 0.64.
| Thermo Fisher Scientific Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $49.68B | $49.36B | 1.01 |
| 2024-12-31 | $47.77B | $49.55B | 0.96 |
| 2024-09-30 | $51.39B | $48.97B | 1.05 |
| 2024-06-30 | $51.08B | $47.42B | 1.08 |
| 2024-03-31 | $51.59B | $45.50B | 1.13 |
| 2023-12-31 | $52.00B | $46.72B | 1.11 |
| 2023-09-30 | $51.71B | $45.35B | 1.14 |
| 2023-06-30 | $50.30B | $43.80B | 1.15 |
| 2023-03-31 | $52.35B | $42.31B | 1.24 |
| 2022-12-31 | $53.12B | $44.03B | 1.21 |
| 2022-09-30 | $46.93B | $43.61B | 1.08 |
| 2022-06-30 | $48.23B | $42.35B | 1.14 |
| 2022-03-31 | $51.73B | $41.02B | 1.26 |
| 2021-12-31 | $54.27B | $40.86B | 1.33 |
| 2021-09-30 | $34.89B | $38.71B | 0.90 |
| 2021-06-30 | $30.84B | $36.85B | 0.84 |
| 2021-03-31 | $30.87B | $35.06B | 0.88 |
| 2020-12-31 | $34.54B | $34.52B | 1.00 |
| 2020-09-30 | $32.24B | $31.82B | 1.01 |
| 2020-06-30 | $31.72B | $29.88B | 1.06 |
| 2020-03-31 | $30.13B | $28.56B | 1.06 |
| 2019-12-31 | $28.71B | $29.68B | 0.97 |
| 2019-09-30 | $27.37B | $29.36B | 0.93 |
| 2019-06-30 | $29.24B | $28.73B | 1.02 |
| 2019-03-31 | $27.90B | $27.69B | 1.01 |
| 2018-12-31 | $28.65B | $27.59B | 1.04 |
| 2018-09-30 | $28.19B | $26.89B | 1.05 |
| 2018-06-30 | $28.96B | $26.45B | 1.10 |
| 2018-03-31 | $30.46B | $26.12B | 1.17 |
| 2017-12-31 | $31.26B | $25.41B | 1.23 |
| 2017-09-30 | $31.28B | $24.70B | 1.27 |
| 2017-06-30 | $24.12B | $22.39B | 1.08 |
| 2017-03-31 | $24.42B | $21.80B | 1.12 |
| 2016-12-31 | $24.37B | $21.54B | 1.13 |
| 2016-09-30 | $26.35B | $21.66B | 1.22 |
| 2016-06-30 | $20.99B | $21.26B | 0.99 |
| 2016-03-31 | $22.03B | $20.92B | 1.05 |
| 2015-12-31 | $19.48B | $21.35B | 0.91 |
| 2015-09-30 | $20.30B | $20.85B | 0.97 |
| 2015-06-30 | $21.10B | $20.68B | 1.02 |
| 2015-03-31 | $21.94B | $19.92B | 1.10 |
| 2014-12-31 | $22.30B | $20.55B | 1.09 |
| 2014-09-30 | $22.18B | $20.51B | 1.08 |
| 2014-06-30 | $23.66B | $20.66B | 1.15 |
| 2014-03-31 | $25.70B | $20.43B | 1.26 |
| 2013-12-31 | $15.01B | $16.86B | 0.89 |
| 2013-09-30 | $11.84B | $16.44B | 0.72 |
| 2013-06-30 | $11.83B | $15.80B | 0.75 |
| 2013-03-31 | $11.81B | $15.60B | 0.76 |
| 2012-12-31 | $11.98B | $15.47B | 0.78 |
| 2012-09-30 | $12.29B | $15.29B | 0.80 |
| 2012-06-30 | $11.27B | $15.09B | 0.75 |
| 2012-03-31 | $11.53B | $15.29B | 0.75 |
| 2011-12-31 | $11.80B | $15.04B | 0.78 |
| 2011-09-30 | $11.80B | $15.20B | 0.78 |
| 2011-06-30 | $8.41B | $15.67B | 0.54 |
| 2011-03-31 | $8.18B | $15.26B | 0.54 |
| 2010-12-31 | $5.99B | $15.36B | 0.39 |
| 2010-09-30 | $6.14B | $15.40B | 0.40 |
| 2010-06-30 | $5.94B | $15.35B | 0.39 |
| 2010-03-31 | $6.15B | $15.48B | 0.40 |
| 2009-12-31 | $6.19B | $15.43B | 0.40 |
| 2009-09-30 | $6.02B | $15.40B | 0.39 |
| 2009-06-30 | $6.08B | $15.08B | 0.40 |
| 2009-03-31 | $6.04B | $14.99B | 0.40 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $155.550B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.004B | 88.48 |
| Edwards Lifesciences (EW) | United States | $45.755B | 30.00 |
| Alcon (ALC) | Switzerland | $44.308B | 29.94 |
| IDEXX Laboratories (IDXX) | United States | $41.667B | 47.88 |
| DexCom (DXCM) | United States | $33.517B | 51.81 |
| STERIS (STE) | Ireland | $24.719B | 27.26 |
| IQVIA Holdings (IQV) | United States | $24.708B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.055B | 28.61 |
| Waters (WAT) | United States | $21.392B | 30.18 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.121B | 0.00 |
| Hologic (HOLX) | United States | $12.655B | 13.75 |
| Penumbra (PEN) | United States | $10.870B | 85.31 |
| Sysmex ADR (SSMXY) | Japan | $10.657B | 30.23 |
| Masimo (MASI) | United States | $8.438B | 31.12 |
| Globus Medical (GMED) | United States | $8.424B | 19.76 |
| Teleflex (TFX) | United States | $5.713B | 9.43 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.112B | 89.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.213B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.421B | 14.42 |
| Veracyte (VCYT) | United States | $2.287B | 32.09 |
| Nihon Kohden (NHNKY) | Japan | $2.213B | 25.38 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.894B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.537B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 118.04 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.055B | 5.61 |
| SiBone (SIBN) | United States | $0.843B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.78 |
| Mesa Laboratories (MLAB) | United States | $0.665B | 14.54 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.43 |
| Delcath Systems (DCTH) | United States | $0.596B | 0.00 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| NeuroPace (NPCE) | United States | $0.574B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| AxoGen (AXGN) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.474B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 12.13 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.165B | 0.00 |
| 908 Devices (MASS) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.141B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 44.60 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |